Clinical Trial Landscape

SYNCHRONIZE, LIVERAGE, and the full Phase 3 program

The Phase 3 Buildout

Boehringer Ingelheim is running parallel Phase 3 programs for survodutide across obesity and MASH. This unit maps the SYNCHRONIZE obesity trials, the LIVERAGE MASH program, the cardiovascular outcomes trial, and the design decisions that shape each study.

Interactive Trial Timeline

Explore the Phase 3 trial program, enrollment targets, and expected readout dates.

trial timeline explorer

Knowledge Check

Test your understanding of the survodutide clinical trial program.

Practice

Apply clinical trial concepts before moving to safety data.